{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:07:58Z","timestamp":1782205678997,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.idc.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T12:38:13Z","timestamp":1575981493000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bugs and Drugs"],"prefix":"10.1016","volume":"34","author":[{"given":"Erin M.","family":"Gentry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Passaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2019.10.001_bib1","first-page":"370","article-title":"Does antibiotic restriction prevent resistance?","volume":"4","author":"Mcgowan","year":"1996","journal-title":"New Horiz"},{"key":"10.1016\/j.idc.2019.10.001_bib2","series-title":"Antibiotic resistance threats in the United States","first-page":"11","author":"Frieden","year":"2013"},{"key":"10.1016\/j.idc.2019.10.001_bib3","unstructured":"The White House. Report to the president on combating antibiotic resistance. 2014. Available at: https:\/\/www.cdc.gov\/drugresistance\/pdf\/report-to-the-president-on-combating-antibiotic-resistance.pdf. Accessed March 4, 2019."},{"key":"10.1016\/j.idc.2019.10.001_bib4","author":"Obama"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.10.001_bib7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.10.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2019.10.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.idc.2016.04.009","article-title":"Building a successful infection prevention program: key components, processes, and economics","author":"Dhar","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2019.10.001_bib12","doi-asserted-by":"crossref","DOI":"10.1017\/ice.2015.333","article-title":"Necessary infrastructure of infection prevention and healthcare epidemiology programs: a review","author":"Bryant","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/647779","article-title":"Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report","volume":"19","author":"Scheckler","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.idc.2019.10.001_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajic.2016.02.004","article-title":"APIC professional and practice standards","volume":"44","author":"Bubb","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2019.10.001_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajic.2008.11.001","article-title":"Staffing and structure of infection prevention and control programs","author":"Stone","year":"2009","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.idc.2019.10.001_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/1475-6773.12530","article-title":"Impact of state reporting laws on central line-associated bloodstream infection rates in US adult intensive care units","volume":"52","author":"Liu","year":"2017","journal-title":"Health Serv Res"},{"issue":"10","key":"10.1016\/j.idc.2019.10.001_bib17","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.ajic.2014.06.001","article-title":"Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative","volume":"42","author":"Marsteller","year":"2014","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cid\/ciy075","article-title":"The standardized antimicrobial administration ratio: a new metric for measuring and comparing antibiotic use","volume":"67","author":"Van Santen","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajic.2012.01.001","article-title":"Antimicrobial stewardship: a collaborative partnership between infection preventionists and health care epidemiologists","volume":"40","author":"Moody","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2019.10.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcna.2018.05.002","article-title":"The role of the hospital epidemiologist in antibiotic stewardship","author":"Abbas","year":"2018","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/ice.2018.33","article-title":"Antimicrobial stewardship and infection prevention - leveraging the synergy: a position paper update","volume":"39","author":"Lou","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2019.10.001_bib22","first-page":"1","article-title":"Integrating bedside nurses into antibiotic stewardship: a practical approach","author":"Monsees","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib23","first-page":"68","article-title":"The expanding role of antimicrobial stewardship programs in hospitals in the United States: lessons learned from a multisite qualitative study","volume":"44","author":"Kapadia","year":"2018","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.idc.2019.10.001_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QCO.0b013e3283483262","article-title":"Antibiotic stewardship: overcoming implementation barriers","volume":"24","author":"Bal","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.10.001_bib25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajic.2018.04.202","article-title":"Infection prevention staffing and resources in US acute care hospitals: results from the APIC MegaSurvey","volume":"46","author":"Pogorzelska-Maziarz","year":"2018","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/oxfordjournals.aje.a113990","article-title":"The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals","volume":"121","author":"Haley","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.idc.2019.10.001_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajic.2017.11.006","article-title":"A\u00a0systematic approach to quantifying infection prevention staffing and coverage needs","volume":"46","author":"Bartles","year":"2018","journal-title":"Am J Infect Control"},{"issue":"104","key":"10.1016\/j.idc.2019.10.001_bib28","first-page":"1","article-title":"Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings","volume":"7","author":"Morris","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"21","key":"10.1016\/j.idc.2019.10.001_bib29","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2146\/ajhp160825","article-title":"Development and application of an objective staffing calculator for antimicrobial stewardship program in the Veterans Health Administration","volume":"74","author":"Echevarria","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.idc.2019.10.001_bib30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/cid\/ciy255","article-title":"Essential resources and strategies for antibiotic stewardship programs in the acute care setting","volume":"67","author":"Doernberg","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"04","key":"10.1016\/j.idc.2019.10.001_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/658946","article-title":"Improving antimicrobial stewardship the evolution of programmatic strategies and barriers","volume":"32","author":"Johannsson","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/21505594.2016.1188234","article-title":"Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae","volume":"8","author":"Wong","year":"2017","journal-title":"Virulence"},{"issue":"148","key":"10.1016\/j.idc.2019.10.001_bib33","first-page":"1","article-title":"Tracking a hospital outbreak of carbapenem resistant Klebsiella pneumoniae with whole-genome sequencing","volume":"4","author":"Snitkin","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.idc.2019.10.001_bib34","series-title":"Facility Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE)","year":"2015"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhin.2018.02.003","article-title":"Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience","volume":"99","author":"Legeay","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.idc.2019.10.001_bib36","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/AAC.00825-16","article-title":"Clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs: a systematic review and meta-analysis","volume":"60","author":"Karanika","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2019.10.001_bib37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.10.001_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhin.2015.05.006","article-title":"Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis","volume":"91","author":"Sarma","year":"2015","journal-title":"J\u00a0Hosp Infect"},{"issue":"9","key":"10.1016\/j.idc.2019.10.001_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.15585\/mmwr.mm6509e1","article-title":"Morbidity and Mortality Weekly Report vital signs: preventing antibiotic-resistant infections in hospitals-United States, 2014","volume":"65","author":"Weiner","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2019.10.001_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/ice.2014.12","article-title":"Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit","volume":"36","author":"Gidengil","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.idc.2019.10.001_bib41","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/CCM.0000000000000501","article-title":"Horizontal infection control strategy decreases methicillin-resistant Staphylococcus aureus infection and eliminates bacteremia in a surgical ICU without active surveillance","volume":"42","author":"Traa","year":"2014","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.idc.2019.10.001_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/507914","article-title":"Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia","volume":"27","author":"Shitrit","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"24","key":"10.1016\/j.idc.2019.10.001_bib43","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2019.10.001_bib44","doi-asserted-by":"crossref","first-page":"e13065","DOI":"10.1111\/ijcp.13065","article-title":"Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention","volume":"72","author":"Ohashi","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.idc.2019.10.001_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.diagmicrobio.2017.10.001","article-title":"Impact of a pharmacist driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: a propensity score-matched quasi-experimental study","volume":"90","author":"Smith","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cid\/cix315","article-title":"An automated, pharmacist-driven initiative improves quality of care for Staphylococcus aureus bacteremia","volume":"65","author":"Wenzler","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.10.001_bib47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajic.2016.02.029","article-title":"Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections","volume":"44","author":"Frenette","year":"2016","journal-title":"Am J Infect Control"},{"issue":"21","key":"10.1016\/j.idc.2019.10.001_bib48","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1001\/jama.2015.5387","article-title":"Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery","volume":"313","author":"Schweizer","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2019.10.001_bib49","first-page":"1","article-title":"Association of screening and treatment for preoperative asymptomatic bacteriuria with postoperative outcomes among US veterans","volume":"02132","author":"Salazar","year":"2018","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.idc.2019.10.001_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.idc.2019.10.001_bib52","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/phar.1288","article-title":"Penicillin skin testing: potential implications for antimicrobial stewardship","volume":"33","author":"Unger","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2146\/ajhp160233","article-title":"Penicillin skin testing as an antimicrobial stewardship initiative","volume":"74","author":"Jones","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.idc.2019.10.001_bib54","article-title":"New avenues for antimicrobial stewardship: the case for penicillin skin testing by pharmacists","author":"Cheon","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"Supple2","key":"10.1016\/j.idc.2019.10.001_bib56","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1086\/519258","article-title":"Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1\/027 strain","volume":"45","author":"Valiquette","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1473-3099(16)30397-8","article-title":"Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis","volume":"17","author":"Lawes","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.10.001_bib58","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1017\/ice.2016.210","article-title":"Inappropriate Clostridium difficile testing and consequent overtreatment and inaccurate publicly reported metrics","volume":"37","author":"Kelly","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"10.1016\/j.idc.2019.10.001_bib59","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","article-title":"Overdiagnosis of Clostridium difficile infection in the molecular test era","volume":"175","author":"Polage","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.idc.2019.10.001_bib60","first-page":"1","article-title":"Diagnostic stewardship of C.\u00a0difficile testing: a quasi-experimental antimicrobial stewardship study","author":"Christensen","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.idc.2019.10.001_bib61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1017\/ice.2018.51","article-title":"Reducing Clostridium difficile colitis rates via cost-saving diagnostic stewardship","volume":"39","author":"Yen","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.idc.2019.10.001_bib62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1017\/ice.2017.16","article-title":"The use of a computerized provider order entry alert to decrease rates of Clostridium difficile testing in young pediatric patients","volume":"38","author":"Nicholson","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.idc.2019.10.001_bib63","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1017\/ice.2017.161","article-title":"The impact of a comptuterized clincial decision support tool on inappropriate Clostridium difficile testing","volume":"38","author":"White","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.idc.2019.10.001_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00125-17","article-title":"Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of Clostridium difficile infection","volume":"61","author":"Shea","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2019.10.001_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-11-187","article-title":"Unnecessary use of fluoroquinolone antibiotics in hospitalized patients","volume":"11","author":"Werner","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2019.10.001_bib66","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/civ696","article-title":"Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections","volume":"61","author":"Cai","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2019.10.001_bib67","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2015.1878","article-title":"Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria","volume":"175","author":"Trautner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.idc.2019.10.001_bib68","first-page":"1","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.10.001_bib69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamainternmed.2017.7290","article-title":"An implementation guide to reducing overtreatment of asymptomatic bacteriuria","volume":"178","author":"Daniel","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"02","key":"10.1016\/j.idc.2019.10.001_bib70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/674848","article-title":"Evaluation of an antimicrobial stewardship approach to minimize overuse of antibiotics in patients with asymptomatic bacteriuria","volume":"35","author":"Kelley","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2019.10.001_bib71","article-title":"Implementation of a nurse driven protocol for catheter removal to decrease catheter-associated urinary tract infection rate in a surgical trauma ICU","author":"Tyson","year":"2018","journal-title":"J\u00a0Intensive Care Med"},{"issue":"4","key":"10.1016\/j.idc.2019.10.001_bib72","article-title":"Antibiotics for asymptomatic bacteriuria","author":"Zalmanovici","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:14:31Z","timestamp":1760195671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552019300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0891552019300807"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2019.10.001","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bugs and Drugs","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}